Parkinson's disease: Clues to aetiology from a toxin

This publication has 19 references indexed in Scilit:

• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
  Nature, 1984
• Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
  European Journal of Pharmacology, 1984
• AETIOLOGY OF PARKINSON'S DISEASE
  The Lancet, 1983
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
  Proceedings of the National Academy of Sciences, 1983
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• Cigarette smoking and Parkinson disease
  Neurology, 1980
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979
• Stereotaxic Mapping of the Monoamine Pathways in the Rat Brain*
  Acta Physiologica Scandinavica, 1971
• Aromatic Amino Acids and Modification of Parkinsonism
  New England Journal of Medicine, 1967